Dr. Hahn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd
Houston, TX 77030
Education & Training
University of Texas Health Science Center at HoustonFellowship, Medical Oncology, 2019 - 2021
University of Utah HealthResidency, Internal Medicine, 2016 - 2019
University of Tennessee Health Science Center College of MedicineClass of 2015
Certifications & Licensure
TX State Medical License 2020 - 2025
UT State Medical License 2016 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Body composition in recurrent prostate cancer and the role of steroidogenic genotype.Neha Venkatesh, Rebecca S Tidwell, Yao Yu, Ana Aparicio, Amado J Zurita
Endocrine-Related Cancer. 2024-12-01 - Belzutifan Efficacy and Tolerability in Patients with Sporadic Metastatic Clear Cell Renal Cell Carcinoma.Emily Wang, Eric S Rupe, Sagar S Mukhida, Andrew C Johns, Matthew T Campbell
European Urology Focus. 2024-09-21 - 1 citationsA phase II trial of apalutamide for intermediate-risk prostate cancer and molecular correlates.Andrew W Hahn, Ganiraju C Manyam, Brian F Chapin, Miao Zhang, Yao Yu
BJU International. 2024-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
